Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

Florent Malard, Myriam Labopin, Christina Cho, Didier Blaise, Esperanza B. Papadopoulos, Jakob Passweg, Richard O'Reilly, Edouard Forcade, Molly Maloy, Liisa Volin, Hugo Castro-Malaspina, Yosr Hicheri, Ann A. Jakubowski, Corentin Orvain, Sergio Giralt, Mohamad Mohty, Arnon Nagler, Miguel-Angel Perales

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number127
JournalJournal of Hematology & Oncology
Volume11
Number of pages11
ISSN1756-8722
DOIs
Publication statusPublished - 20 Oct 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Acute myeloid leukemia
  • T cell depletion
  • CD34-selected graft
  • Antithymocyte globulin
  • Allogeneic hematopoietic cell transplantation
  • VERSUS-HOST-DISEASE
  • ACUTE MYELOGENOUS LEUKEMIA
  • ANTI-THYMOCYTE GLOBULIN
  • CHRONIC GRAFT
  • UNRELATED DONOR
  • HEMATOLOGIC MALIGNANCIES
  • ANTITHYMOCYTE GLOBULIN
  • CLINICAL-TRIALS
  • BONE-MARROW
  • OPEN-LABEL
  • 3122 Cancers

Cite this